AATS Evaluation and Management of N2+ Non-Small Cell Lung Cancer 2026 Consensus Document

from Clinical Guideline InSights · host Guideline Central

The 2026 Evaluation and Management of N2+ Non-Small Cell Lung Cancer consensus document, highlighting key consensus statements on staging, use of chemoimmunotherapy, resectability, and more. Evaluation and Management of N2+ Non-Small Cell Lung CancerAmerican Association for Thoracic SurgeryMay 2, 2026Guideline Summary: https://www.guidelinecentral.com/guideline/5216039/Full-Text: https://www.jtcvs.org/article/S0022-5223(26)00899-8/pdf

Episode metadata supplied by the publisher feed · Published May 19, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

AATS Evaluation and Management of N2+ Non-Small Cell Lung Cancer 2026 Consensus Document

0:00 3:56

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Clinical Guideline InSights?

This episode is 3 minutes long.

When was this Clinical Guideline InSights episode published?

This episode was published on May 19, 2026.

Can I download this Clinical Guideline InSights episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!